Wednesday, November 12, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Nike Faces Critical Test as Quarterly Results Loom

Dieter Jaworski by Dieter Jaworski
September 28, 2025
in Stocks
0
Nike Stock
0
SHARES
51
VIEWS
Share on FacebookShare on Twitter

All eyes are on sportswear titan Nike this week, with the company scheduled to release its first-quarter financial results after markets close on Tuesday. The announcement arrives amidst a stark divergence in market sentiment: while consensus earnings forecasts appear bleak, several major Wall Street institutions are striking an unexpectedly optimistic tone. The pivotal question remains whether Nike can defy expectations or if it is headed for another disappointing performance.

Wall Street’s Surprising Confidence

Contrary to the prevailing gloomy outlook, a number of prominent investment banks are expressing bullishness on Nike’s prospects. Goldman Sachs has reaffirmed its “Buy” recommendation, maintaining a price target of $85. Showing even greater confidence, RBC Capital Markets upgraded the stock to “Outperform,” projecting a potential rise to $90 per share, a forecast largely based on anticipated improvements within the running shoe division.

This positive sentiment is echoed by other financial houses. UBS has increased its price objective to $71, while Telsey Advisory Group raised its target to $75. Jefferies remains the most ambitious, standing by a “Buy” rating and a price target of $115.

High Stakes and Harsh Realities

The optimism from analysts stands in sharp contrast to the concrete financial projections for the quarter. Market experts anticipate earnings per share to land between just $0.27 and $0.28, which would represent a dramatic year-over-year decline of 61.5 percent. Revenue is expected to come in at approximately $11 billion.

Should investors sell immediately? Or is it worth buying Nike?

Investors will be scrutinizing three critical areas for signs of the company’s future trajectory:
* Performance in the crucial Chinese market
* Progress in reducing excess inventory levels
* The margin impact of recent U.S. tariff policies

The last point carries significant weight; Nike has estimated that tariff policies could impose additional costs of up to $1.5 billion by fiscal year 2026.

Strategic Moves and Market Pressure

In a strategic move just days before the earnings release, Nike announced a new collaboration with the shapewear brand SKIMS, launching an activewear line on September 26. Market researchers view this partnership as a potentially innovative step, though its ability to offset fundamental operational challenges is uncertain.

Nike’s shares continue to struggle, heading for a potential fifth consecutive weekly loss. Since a price surge in June, the stock has been trading in a narrow range between $70 and $80, reflecting persistent market uncertainty. This pressure was compounded by a recent sale of 110,000 shares by Executive Chairman Mark G. Parker.

Ad

Nike Stock: Buy or Sell?! New Nike Analysis from November 12 delivers the answer:

The latest Nike figures speak for themselves: Urgent action needed for Nike investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 12.

Nike: Buy or sell? Read more here...

Tags: Nike
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Royal Gold Stock
Stocks

Royal Gold Shares Surge to Record High on Acquisition Momentum

September 29, 2025
Unitedhealth Stock
Stocks

UnitedHealth Shares Present Conflicting Outlook for Investors

September 29, 2025
ASML Stock
Stocks

ASML Forges Strategic AI Alliance to Bolster Semiconductor Dominance

September 29, 2025
Next Post
Realty Income Stock

Realty Income Secures Major Funding for Strategic Growth Push

Synopsys Stock

Synopsys Shares Plunge Following Disappointing Quarterly Results

UPS Stock

Is UPS's Dividend Payout Sustainable Amid Mounting Pressure?

Recommended

Micron Stock

Micron Stock Surges on AI Demand as Investors Eye Critical Earnings

2 months ago

TG Therapeutics Short Interest Declines Indicating Potential Shift in Market Sentiment

2 years ago
Entertainment Trading online

Netflixs Triumph A ForwardThinking Approach to Streaming Success

2 years ago
Healthcare Services Stock Exchange

Analyst Initiates Coverage on RenovoRx Inc with Strong Buy Rating and 4 Price Target

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Rite Aid’s Final Chapter: Shareholders Face Total Wipeout

Allakos Reaches Corporate Endpoint with Concentra Acquisition

Nel ASA Shares Surge on Landmark Hydrogen Contract

Clash of Titans: Palantir CEO and “Big Short” Investor Lock Horns Over AI Valuation

BioNTech Shares Surge on Upbeat Revenue Outlook

Shareholder Rebellion Intensifies at Tiptree Over Fortegra Sale

Trending

Novo Nordisk Stock
Analysis

Novo Nordisk Shares: Sustainable Recovery or Temporary Bounce?

by Felix Baarz
November 12, 2025
0

Novo Nordisk's stock is showing signs of life after a prolonged downturn, but investors remain divided on...

Tuniu Stock

Tuniu Faces Nasdaq Delisting Deadline as Shares Languish

November 12, 2025
Asml Stock

ASML’s Asian Strategy: Balancing Korean Expansion Against Chinese Headwinds

November 12, 2025
Rite Aidration Stock

Rite Aid’s Final Chapter: Shareholders Face Total Wipeout

November 12, 2025
Allakos Stock

Allakos Reaches Corporate Endpoint with Concentra Acquisition

November 12, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Novo Nordisk Shares: Sustainable Recovery or Temporary Bounce?
  • Tuniu Faces Nasdaq Delisting Deadline as Shares Languish
  • ASML’s Asian Strategy: Balancing Korean Expansion Against Chinese Headwinds

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com